Tubacin suppresses proliferation and induces apoptosis of acute lymphoblastic leukemia cells

Leukemia and Lymphoma

Volumn 52, Issue 8, 2011, Pages 1544-1555

  Aldana Masangkay, Grace I ^a,b   Rodriguez Gonzalez, Agustin ^c   Lin, Tara ^d   Ikeda, Alan K ^b   Hsieh, Yao Te ^e   Kim, Yong Mi ^e   Lomenick, Brett ^b   Okemoto, Kazuo ^f   Landaw, Elliot M ^b   Wang, Dongpeng ^g   Mazitschek, Ralph ^g   Bradner, James E ^h   Sakamoto, Kathleen M ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f OHIO STATE UNIVERSITY   (United States)

^g MASSACHUSETTS GENERAL HOSPITAL   (United States)

^h DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

aggresome pathway; ALL; HDAC6; Tubacin

Indexed keywords

ALPHA TUBULIN; ASPARAGINASE; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; BORTEZOMIB; DEXAMETHASONE; HISTONE DEACETYLASE 6; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NILTUBACIN; OUABAIN; OXAZOLE DERIVATIVE; TUBACIN; UNCLASSIFIED DRUG; VINCRISTINE; VORINOSTAT;

ACUTE LYMPHOBLASTIC LEUKEMIA; AGGRESOME; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER COMBINATION CHEMOTHERAPY; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME INHIBITION; HEMATOPOIETIC CELL; HISTONE ACETYLATION; HISTONE UBIQUITINATION; HUMAN; HUMAN CELL; IC 50; MOUSE; MULTIPLE MYELOMA; NONHUMAN; PRE B LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN CLEAVAGE; T LYMPHOCYTE;

ACETYLATION; ANILIDES; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; HISTONE DEACETYLASE INHIBITORS; HISTONE DEACETYLASES; HUMANS; HYDROXAMIC ACIDS; INHIBITORY CONCENTRATION 50; JURKAT CELLS; MICE; MICE, INBRED NOD; MICE, SCID; POLY(ADP-RIBOSE) POLYMERASES; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; SIGNAL TRANSDUCTION; TUBULIN; VINCRISTINE; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 79960435624     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2011.570821     Document Type: Article

References (35)

1. The Leukemia & Lymphoma Society. Facts 2010-2011 [Internet]. 2010. Available from: http://www.lls.org/resource center/freeeducationmaterials/ generalcancer/facts
2. American Cancer Society. Cancer Facts & Figures 2010. Atlanta: ACS 2010.
3. Reichmann R. Acute lymphoblastic leukaemia: a review. Trinity Stud Med J 2000;1:26-28
4. Aldana-Masangkay GI, Sakamoto KM. HDAC6 and its role in cancer. J Biomed Biotech 2011;2011:875824
5. Matsuyama A, Shimazu T, Sumida Y, et al. In vivo destabilization of dynamic microtubules by HDAC6-mediated deacetylation. EMBO J 2002;21:6820-6831 (Pubitemid 36014554)
6. Valenzuela-Fernandez A, Roman-Cabrero J, Serrador JM, Sanchez-Madrid F. HDAC6: a key regulator of cytoskeleton, cell migration and cell-cell interactions. Trends Cell Biol 2008;18:291-297
7. Cabrero JR, Serrador JM, Barreiro O, et al. Lymphocyte chemotaxis is regulated by histone deacetylase 6, independently of its deacetylase activity. Mol Biol Cell 2006;17:3435-3445 (Pubitemid 44156438)
8. Arce CA, Casale CH, Barra HS. Submembraneous microtubule cytoskeleton: regulation of ATPases by interaction with actetylated tubulin. FEBS J 2008;275:4664-4674
9. Hideshima T, Bradner JE, Wong J, et al. Small-molecule inhibition of proteasome and aggresome function induces synergistic antitumor activity in multiple myeloma. Proc Natl Acad Sci USA 2005;102:8567-8572 (Pubitemid 40862776)
10. Rodriguez-Gonzalez A, Lin T, Ikeda AK, Simms-Waldrip T, Fu C, Sakamoto KM. Role of the aggresome pathway in cancer: targeting histone deacetylase 6-dependent protein degradation. Cancer Res 2008;68:2557-2560 (Pubitemid 351556250)
11. Haggarty SJ, Koeller KM, Wong JC, Grozinger CM, Schreiber SL. Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation. Proc Natl Acad Sci USA 2003;100:4389-4394 (Pubitemid 36457739)
12. Haggarty SJ, Koeller KM, Wong JC, Butcher RA, Schreiber SL. Multidimensional chemical genetic analysis of diversityoriented synthesis-derived deacetylase inhibitors using cellbase assays. Chem Biol 2003;10:383-396 (Pubitemid 36610312)
13. Boulares AH, Yakovlev AG, Ivanova V, et al. Role of poly(ADP-ribose) polymerase (PARP) cleavage in apoptosis. J. Biol Chem 1999;274:22932-22940
14. Casale CH, Previtali G, Barra HS. Involvemet of acetylatied tubulin in the regulation of Na?,K?-ATPase activity in cultured astrocytes. FEBS J 2003;534:115-118 (Pubitemid 36084527)
15. James PF, Grupp IL, Grupp G, et al. Identification of a specific role for the Na,K-ATPase alpha 2 isoform as a regulator of calcium in the heart. Mol Cell 1999;3:555-563 (Pubitemid 29268439)
16. Grupp I, Im WB, Lee CO, Lee SW, Pecker MS, Schwartz A. Relation of sodium pump inhibition to positive inotropy at low concentrations of ouabain in rat heart muscle. J Physiol 1985;360:149-160 (Pubitemid 15133989)
17. Rakowski RF, Gadsby DC, de Weer P. Stoichiometry and voltage dependence of the sodium pump in voltage-clamped, internally dialyzed squid giant axon. J Gen Physiol 1989; 93:903-941 (Pubitemid 19138245)
18. Lingrel JB, Kuntzweiler T. Na?,K?-ATPase. J Biol Chem 1994;269:19659-19662
19. Koksoy AA. Na?,K?-ATPase: a review. J Ankara Med Sch 2002;24:73-82
20. Fujiki Y, Hubbard AL, Fowler S, Lazarow PB. Isolation of intracellular membranes by means of sodium carbonate treatment: application to endoplasmic reticulum. J Cell Biol 1982;93:97-102 (Pubitemid 12117045)
21. Alonso A del C, Nunez-Fernandez M, Beltramo DM, Casale CH, Barra HS. Na?,K?-ATPase was found to be the membrane component responsible for the hydrophobic behaviour of the brain membrane tubulin. Biochem Biophys Res Commun 1998;253:924-927
22. Santander VS, Bising CG, Purro SA, Casale CH, Arce CA, Barra HS. Tubulin must be acetylated in order to form a complex with membrane Na?,K?-ATPase and to inhibit its enzyme activity. Mol Cell Biochem 2006;291:167-174 (Pubitemid 44725316)
23. Nobel CS, Aronson JK, van den Dobbelsteen DJ, Slater AFG. Inhibition of Na?-K?-ATPase may be one mechanism contributing to potassium efflux and cell shrinkage in CD95- induced apoptosis. Apoptosis 2000;5:153-163 (Pubitemid 30399389)
24. Esmann M. ATPase and phosphatase activity of Na?,K?- ATPase: molar and specific activity, protein determination. Meth Enzymol 1979;156:105-115
25. Trageser D, Iacobucci I, Nahar R, et al. Pre-B cell receptormediated cell cycle arrest in Philadelphia chromosomepositive acute lymphoblastic leukemia requires IKAROS function. J Exp Med 2009;206:1739-1753
26. Klemm L, Duy C, Iacobucci I, et al. The B cell mutator AID promotes B lymphoid blast crisis and drug resistance in chronic myeloid leukemia. Cancer Cell 2009;16:232-245
27. Dai Y, Rahmani M, Grant S. Proteasome inhibitors potentiate leukemic cell apoptosis induced by the cyclindependent kinase inhibitor flavoripidol through a SAPK/JNK and NF-kappab-dependent process. Oncogene 2003;22: 7108-7122 (Pubitemid 37378543)
28. Tang G, Xu Z, Golman JE. Synergistic effects of the SAPK/ JNK and the proteasome pathway on glial fibrillary acidic protein (GFAP) accumulation in Alexander disease. J Biol Chem 2003;281:38634-38643 (Pubitemid 46041988)
29. Yu X, Hong S, Faustman EM. Cadmium-induced activation of stress signaling pathways, disruption of ubiquitin dependent protein degradation and apoptosis in primary rat Sertoli cellgonocyte cocultures. Toxicol Sci 2008;104:385-396 (Pubitemid 352038260)
30. Davis RJ. Signal transduction by the JNK group of MAP kinases. Cell 2000;103:239-252
31. Rao R, Fiskus W, Yang Y, et al. HDAC6 inhibition enhances 17-AAG-mediated abrogation of hsp90 chaperone function human leukemia cells. Blood 2008;112:1886-1893
32. Kulikov A, Eva A, Kirck U, Boldyrev A, Scheiner-Bobis G. Ouabain activates signaling pathways associated with cell death in human neuroblastoma. Biochim Biophys Acta 2007;1768:1691-1702 (Pubitemid 46890795)
33. Boyault C, Sadoul K, Pabion M, Khochbin S. HDAC6, at the crossroads between cytoskeleton and cell signaling by acetylation and ubiquitination. Oncogene 2007;26:5468-5476 (Pubitemid 47255928)
34. Wang XQ, Xiao AY, Sheline C, et al. Apoptotic insults impair Na?,K?-ATPase activity as a mechanism of neuronal death mediated by concurrent ATP deficiency and oxidant stress. J Cell Biol 2003;116:2099-2110 (Pubitemid 36622306)
35. Namdar M, Perez G, Ngo L, Marks PA. Selective inhibition of histone deacetylase 6 (HDAC6) induces DNA damage and sensitizes transformed cells to anticancer agents. Proc Natl Acad Sci USA 2001;107:20003-20008